top of page

CeleCor

CeleCor Therapeutics

Wondros

2022

Director of Product Design

Summary

CeleCor Therapeutics has developed a revolutionary new first-response therapy for heart attack patients. In its 3rd Phase of clinical trials, zalunfiban is showing great promise for FDA approval.

This site was developed to showcase how zalunfiban works and allow potential investors and therapy advocates to download a product backgrounder, inciting the interest of potential buyers of the technology.

Responsive Product Showcase; MSAA Treatment Finder

Select a campaign to learn more.

50% of heart-attack deaths occur before a patient reaches the hospital, CeleCor is fighting to change that.

Kristen Suszek Logo

From creating bespoke User Experiences to visually stunning Photography and Design, your creative needs are meticulously executed, allowing your brand to stand head and shoulders above the rest.  

LET'S CONNECT
  • LinkedIn

© 2024 Kristen L. Suszek, All rights Reserved.   
Web Accessibility Statement

bottom of page